(4'R)-7'-fluorospiro[1-azabicyclo[3.2.1]octane-4,2'-3,4-dihydrochromene]-4'-amine
C15H19FN2O — CID 105366461
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4'R)-7'-fluorospiro[1-azabicyclo[3.2.1]octane-4,2'-3,4-dihydrochromene]-4'-amine
(4'R)-7'-fluorospiro[1-azabicyclo[3.2.1]octane-4,2'-3,4-dihydrochromene]-4'-amine (PubChem CID 105366461) has the molecular formula C15H19FN2O and a molecular weight of 262.33 g/mol. Its IUPAC name is (4'R)-7'-fluorospiro[1-azabicyclo[3.2.1]octane-4,2'-3,4-dihydrochromene]-4'-amine.
Molecular Properties
| Compound Name | (4'R)-7'-fluorospiro[1-azabicyclo[3.2.1]octane-4,2'-3,4-dihydrochromene]-4'-amine |
|---|---|
| PubChem CID | 105366461 |
| Molecular Formula | C15H19FN2O |
| Molecular Weight | 262.33 g/mol |
| Exact Mass | 262.15 |
| IUPAC Name | (4'R)-7'-fluorospiro[1-azabicyclo[3.2.1]octane-4,2'-3,4-dihydrochromene]-4'-amine |
| SMILES | N[C@@H]1CC2(CCN3CCC2C3)Oc2cc(F)ccc21 |
| InChI | InChI=1S/C15H19FN2O/c16-11-1-2-12-13(17)8-15(19-14(12)7-11)4-6-18-5-3-10(15)9-18/h1-2,7,10,13H,3-6,8-9,17H2/t10?,13-,15?/m1/s1 |
| InChIKey | OBFPMEOINACLFA-VROQLPPWSA-N |
| XLogP | 2.07 |
| TPSA | 38.49 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | |
| Heavy Atoms | 19 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 262.33 |
| LogP ≤ 5 | 2.07 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 105366461 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.